Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Obes Surg ; 32(3): 786-791, 2022 03.
Article in English | MEDLINE | ID: mdl-35066783

ABSTRACT

PURPOSE: The aim of our study was to assess long-term opioid use following bariatric surgery in patients on preoperative narcotics. METHODS: We evaluated patients utilizing preoperative opioids (OP) who underwent primary laparoscopic Roux-en-Y gastric bypass (LRYGB) from 2013 to 2020. Patients were propensity-matched to those without preoperative opioid use (NOP) by demographics and comorbidities. Our objectives were to compare opioid use at 1 and 3 years after surgery and evaluate perioperative outcomes. RESULTS: A total of 806 patients, matched 1:1 were evaluated, with 82.7% being females. Mean age was 46.5 years in the OP and 45.6 years in the NOP (p = 0.0018), preoperative BMI was 45.8 in the OP and 46.1 in the NOP (p = 0.695). All patients were followed up for 1 year. In the OP, 156 (38.7%) patients were taking opioids 1 year after surgery as opposed to 27 (6.7%) in the NOP (p < 0.0001). Three years after surgery, 74 (37.5%) patients in the OP and 27 (14.4%) in the NOP were taking outpatient opioids (p < 0.0001). There was no statistically significant difference between OP and NOP groups in terms of readmissions (9.4% vs. 5.7% p = 0.06), reinterventions (3.7 vs. 1.7% p = 0.13), reoperations (3.5% vs. 1.5% p = 0.11), or emergency room visits (8.9% vs. 7.2% p = 0.44). There were no mortalities. CONCLUSION: Most patients requiring preoperative opioids can be weaned off after bariatric surgery. Enhanced recovery pathways are key to obtaining these results. Preoperative opioid use is not associated with increased complications compared to opioid-naïve patients.


Subject(s)
Bariatric Surgery , Gastric Bypass , Laparoscopy , Obesity, Morbid , Analgesics, Opioid/therapeutic use , Bariatric Surgery/adverse effects , Female , Gastric Bypass/methods , Humans , Laparoscopy/adverse effects , Male , Middle Aged , Obesity, Morbid/surgery , Retrospective Studies , Treatment Outcome
2.
Reprod Toxicol ; 59: 159-66, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26582257

ABSTRACT

Alkyl dimethyl benzyl ammonium chloride (ADBAC) and didecyl dimethyl ammonium chloride (DDAC) are common ingredients in household bathroom and kitchen cleaning sprays. ADBAC+DDAC cause reproductive toxicity in mice. The aim of the present study was to investigate gender-specific reproductive effects from ADBAC+DDAC. Female reproduction was assessed through ovulation, oocyte implantation, and estrus cycling. Male reproductive function was assessed by sperm concentration, motility, and viability. Numbers of corpora lutea were not different after 2 weeks, but decreased after 8 weeks of ADBAC+DDAC exposure. Dams exposed for 5 weeks to ADBAC+DDAC spent significantly less time in estrus. ADBAC+DDAC exposed males exhibited declines in both sperm concentration and motility, but not sperm viability. Subfertility in mice from ADBAC+DDAC exposure is, therefore, mediated through reproductive disturbances in both females and males. While the effect of ADBAC+DDAC exposure on human health is unclear, widespread exposure necessitates further consideration of their potential reproductive toxicity.


Subject(s)
Benzalkonium Compounds/toxicity , Disinfectants/toxicity , Fertility/drug effects , Infertility, Female/chemically induced , Infertility, Male/chemically induced , Quaternary Ammonium Compounds/toxicity , Reproduction/drug effects , Spermatozoa/drug effects , Animals , Cell Survival/drug effects , Embryo Implantation/drug effects , Embryo Loss , Estrous Cycle/drug effects , Female , Infertility, Female/physiopathology , Infertility, Male/physiopathology , Male , Mice , Ovulation/drug effects , Pregnancy , Risk Assessment , Sperm Count , Sperm Motility/drug effects , Spermatozoa/pathology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...